Establishment of MAIDS-defective virus-infected B cell lines and their characterization

Virology

Volumn 244, Issue 2, 1998, Pages 283-293

  Klein, Steven J ^a   Simard, Carole ^a   Jolicoeur, Paul ^a,b,c  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

B cell lines; C57BL 6; MAIDS

Indexed keywords

ANIMAL CELL; ARTICLE; B LYMPHOCYTE ACTIVATION; CELL MIGRATION; CELL SUBPOPULATION; CELL TRANSFORMATION; HELPER CELL; MOUSE; NONHUMAN; POLYCLONAL ACTIVATION; PRIORITY JOURNAL; RETROVIRUS; RODENT DISEASE; TARGET CELL; VIRUS INFECTION; VIRUS REPLICATION;

ANIMALIA; MURINAE; RNA VIRUSES; RODENTIA; UNIDENTIFIED RETROVIRUS;

EID: 0032503224     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1998.9112     Document Type: Article

References (62)

1. Alt F. N., Rosenberg S., Lewis S., Thomas E., Baltimore D. Organization and reorganization of immunoglobulin genes in A-MuLV-transformed cells: Rearrangements of heavy but not light chain genes. Cell. 27:1981;381-390.
2. Alt F. W., Yancopoulos G. D., Blackwell T. K., Wood C., Thomas E., Boss M., Rosenberg N., Tonegawa S., Baltimore D. Ordered rearrangement of immunoglobulin heavy chain variable region segments. EMBO J. 3:1984;1209-1219.
3. Alt F. W., Blackwell T. K., Yancopoulos G. D. Development of the primary antibody repertoire. Science. 238:1987;1079-1087.
4. Astier T., Guillemain B., Laigret F., Mamoun R., Duplan J. F. Serological characterization of C-type retroviruses endogenous to the C57BL/6 mouse and isolated in tumours induced by radiation leukaemia virus (RadLV-Rs). J. Gen. Virol. 61:1982;55-63.
5. Aziz D. C., Hanna Z., Jolicoeur P. Severe immunodeficiency disease induced by a defective murine leukaemia virus. Nature. 338:1989;505-508.
6. Bilello J. A., Kort J. J., MacAuley C., Fredrickson T. N., Yetter R. A., Eiseman J. L. ZDV delays but does not prevent the transmission of MAIDS by LP-BM5 MuLV-infected macrophage-monocytes. J. AIDS. 5:1992;571-576.
7. Caccia N., Kronenberg M., Saxe D., Haars R., Bruns G. A. P., Governman J., Malissen M., Willard H., Yoshikai Y., Simon M., Hood L., Mak T. The T cell receptor B chain genes are located on chromosome 6 in mice and chromosome 7 in humans. Cell. 37:1984;1091-1099.
8. Cerny A., Hügin A. W., Hardy R. R., Hayakawa K., Zinkernagel R. M., Makino M., Morse I. I. I. B cells are required for induction of T cell abnormalities in a murine retrovirus-induced immunodeficiency syndrome. J. Exp. Med. 171:1990;315-320.
9. Chattopadhyay S. K., Lander M. R., Rands E., Lowy D. R. Structure of endogenous murine leukemia virus DNA in mouse genomes. Proc. Natl. Acad. Sci. USA. 77:1980;5774-5778.
10. Chattopadhyay S. K., Morse H. C. III, Makino M., Ruscetti S. K., Hartley H. W. Defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome. Proc. Natl. Acad. Sci. USA. 86:1989;3862-3866.
11. Chattopadhyay S. K., Sengupta D. N., Fredrickson T. N., Morse H. C. III, Hartley J. W. Characteristics and contributions of defective, ecotropic, and mink cell focus-inducing viruses involved in a retrovirus-induced immunodeficiency syndrome of mice. J. Virol. 65:1991;4232-4241.
12. Chen Y. Y., Wang L. C., Huang M. S., Rosenberg N. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement. Genes Dev. 8:1994;688-697.
13. Cheung S. C., Chattopadhyay S. K., Hartley J. W., Morse I. I. I., Pitha P. M. Aberrant expression of cytokine genes in peritoneal macrophages from mice infected with LP-BM5 MuLV, a murine model of AIDS. J. Immunol. 146:1991;121-127.
14. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
15. Dupraz P., Rebai N., Klein S. J., Beaulieu N., Jolicoeur P. The murine AIDS virus gag precursor protein binds to the SH3 domain of c-Abl. J. Virol. 71:1997;2615-2620.
16. Gazzinelli R. T., Giese N. A., Morse H. C. 3rd. In vivo treatment with interleukin 12 protects mice from immune abnormalities observed during murine acquired immunodeficiency syndrome (MAIDS). J. Exp. Med. 180:1994;2199-2208.
17. Giese N. A., Giese T., Morse H. C. 3rd. Murine AIDS is an antigen-driven disease: requirements for major histocompatibility complex class II expression and CD4+ T cells. J. Virol. 68:1994;5819-5824.
18. Gilmore G. L., Cowing C., Mosier D. E. LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice: Inability to recognize a putative viral superantigen does not prevent induction of disease. J. Immunol. 150:1993;185-189.
19. Gorska-Flipot I., Huang M., Cantin M., Rassart E., Massé G., Jolicoeur P. U3 LTR-mediated induction of intracellular immunity by a murine retrovirus: A novel model of latency for retroviruses. J. Virol. 1992;181-216.
20. Green K. A., Crassi K. M., Laman J. D., Schoneveld A., Strawbridge R. R., Foy T. M., Noelle R. J., Green W. R. Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice. J. Virol. 70:1996;2569-2575.
21. Grewal I. S., Flavell R. A. The role of CD40 ligand in costimulation and T-cell activation. Immunol. Rev. 153:1996;85-106.
22. Guillemain B., Astier T., Mamoun R., Duplan J. F. In vitro production and titration assays of B-tropic retroviruses isolated from C57BL mouse tumors induced by radiation leukemia virus (RadLV-Rs): Effect of dexamethasone. Intervirology. 13:1980;65-73.
23. Gulley M. L., Ogata L. C., Thorson J. A., Dailey M. O., Kemp J. D. Identification of a murine pan-T cell antigen which is also expressed during the terminal phases of B cell differentiation. J. Immunol. 140:1988;3751-3757.
24. Haas M., Reshef T. Non-thymic malignant lymphomas induced in C57BL/6 mice by cloned dualtropic viruses isolated from hematopoietic stromal cell lines. Eur. J. Cancer. 16:1980;909-917.
25. Hartley J. W., Fredrickson T. N., Yetter R. A., Makino M., Morse I. I. I. Retrovirus-induced murine acquired immunodeficiency syndrome: natural history of infection and differing susceptibility of inbred mouse strains. J. Virol. 63:1989;1223-1231.
26. Hitoshi Y., Okada Y., Sonoda E., Tominaga A., Makino M., Suzuki K., Kinoshita J., Komuro K., Mizuochi T., Takatsu K. Delayed progression of a murine retrovirus-induced acquired immunodeficiency syndrome in X-linked immunodeficient mice. J. Exp. Med. 177:1993;621-626.
27. Huang M., Simard C., Jolicoeur P. Immunodeficiency and clonal growth of target cells induced by helper-free defective retrovirus. Science. 246:1989;1614-1617.
28. Huang M., Simard C., Kay D. G., Jolicoeur P. The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J. Virol. 65:1991;6562-6571.
29. Jolicoeur P. The murine acquired immunodeficiency syndrome (MAIDS): An animal model to study the AIDS pathogenesis. FASEB J. 5:1991;2398-2405.
30. Kanagawa O., Vaupel B. A., Korsmeyer S. J., Russell J. H. Apoptotic death of lymphocytes in murine acquired immunodeficiency syndrome: involvement of Fas-Fas ligand interaction. Eur. J. Immunol. 25:1995;2421-2427.
31. Kim W. K., Tang Y., Kenny J., Longo D. L., Morse H. C. 3rd. In murine AIDS, B cells are early targets of defective virus and are required for efficient infection and expression of defective virus in T cells and macrophages. J. Virol. 68:1994;6767-6769.
32. Klinken S. P., Fredrickson T. N., Hartley J. W., Yetter R. A., Morse H. C. III. Evolution of B cell lineage lymphomas in mice with a retrovirus-induced immunodeficiency syndrome, MAIDS. J. Immunol. 140:1988;1123-1131.
33. Klinman D. M., Morse I. I. I. Characteristics of B cell proliferation and activation in murine AIDS. J. Immunol. 142:1989;1144-1149.
34. Kubo Y., Nakagawa Y., Kakimi K., Matsui H., Iwashiro M., Kuribayashi K., Masuda T., Hiai H., Hirama T., Yanagawa S. I., Ishimoto A. Presence of transplantable T-lymphoid cells in C57BL/6 mice infected with murine AIDS virus. J. Virol. 66:1992;5691-5695.
35. Legrand E., Guillemain B., Dalculsi R., Laigret F. Leukemogenic activity of B-ecotropic C-type retroviruses isolated from tumors induced by radiation leukemia virus (RadLV-Rs) in C57BL/6 mice. Int. J. Cancer. 30:1982;241-247.
36. Lewis S., Rosenberg N., Alt F., Baltimore D. Continuing kappa-gene rearrangement in a cell line transformed by Abelson murine leukemia virus. Cell. 30:1982;807-816.
37. Luo W., Van de Velde H., von Hoegen I., Parnes J. R., Thielemans K. Ly-1 (CD5), a membrane glycoprotein of mouse T lymphocytes and a subset of B cells, is a natural ligand of the B cell surface protein Lyb-2 (CD72). J. Immunol. 148:1992;1630-1634.
38. Makino M., Winkler D. F., Wunderlich J., Hartley J. W., Morse H. C., Holmes K. L. High expression of NK-1.1 antigen is induced by infection with murine AIDS virus. Immunology. 80:1993;319-325.
39. Makino M., Yoshimatsu K., Azuma M., Okada Y., Hitoshi Y., Yagita H., Takatsu K., Komuro K. Rapid development of murine AIDS is dependent of signals provided by CD54 and CD11a. J. Immunol. 155:1995;974-981.
40. Melchers F., Haasner D., Grawunder U., Kalberer C., Karasuyama H., Winkler T., Rolink A. G. Roles of IgH and L chains and of surrogate H and L chains in the development of cells of the B lymphocyte lineage. Annu. Rev. Immunol. 12:1994;209-225.
41. Misawa Y., Nagaoka H., Kimoto H., Ishii Y., Kitamura K., Tsunetsugu-Yokota Y., Shibuya M., Takemori T. CD43 expression in a B cell lymphoma, WEHI 231, reduces susceptibility to G1 arrest and extends survival in culture upon serum depletion. Eur. J. Immunol. 26:1996;2573-2581.
42. Mistry P. B., Duplan J. F. Propriétés biologiques d'un virus isolé d'une radioleucémie C57BL. Bull. Cancer (Paris). 60:1973;287-300.
43. Morse H. C. III, Chattopadhyay S. K., Makino M., Fredrickson T. N., Hugin A. W., Hartley J. W. Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS. AIDS. 6:1992;607-621.
44. Mosier D. E. Animal models for retrovirus-induced immunodeficiency disease. Immunol. Invest. 15:1986;233-261.
45. Mosier D. E., Yetter R. A., Morse .H. C. III. Functional T lymphocytes are required for a murine retrovirus-induced immunodeficiency disease (MAIDS). J. Exp. Med. 165:1987;1737-1742.
46. Ostberg J. R., Dragone L. L., Driskell T., Moynihan J. A., Phipps R., Barth R. K., Frelinger J. G. Disregulated expression of CD43 (leukosialin, sialophorin) in the B cell lineage leads to immunodeficiency. J. Immunol. 157:1996;4876-4884.
47. Poirier Y., Jolicoeur P. Distinct helper virus requirements for Abelson murine leukemia virus-induced pre-B- and T-cell lymphomas. J. Virol. 63:1989;2088-2098.
48. Pozsgay J. M., Beilharz M. W., Wines B. D., Hess A. D., Pitha P. M. The MA (p15) and p12 regions of the gag gene are sufficient for the pathogenicity of the murine AIDS virus. J. Virol. 67:1993;5989-5999.
49. Roder J., Duwe A. The beige mutation in the mouse selectively impairs natural killer cell function. Nature. 278:1979;451-453.
50. Rosenberg N. Abelson leukemia virus. Curr. Top. Microbiol. Immunol. 101:1982;95-126.
51. Rosenberg N. Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation. Semin. Cancer Biol. 5:1994;95-102.
52. Schlissel M. S., Baltimore D. Activation of immunoglobulin kappa gene rearrangement correlates with the induction of germline kappa gene transcription. Cell. 58:1989;1001-1007.
53. Simard C., Huang M., Jolicoeur P. Murine AIDS is initiated in the lymph nodes draining the site of inoculation, and the infected B cells influence T cells located at distance, in noninfected organs. J. Virol. 68:1994;1903-1912.
54. Simard C., Huang M., Jolicoeur P. Establishment of leukemic T cell lines from mice inoculated with the MAIDS defective virus. Virology. 206:1995;555-563.
55. Simard C., Klein S. J., Mak T., Jolicoeur P. Studies on the susceptibility of nude, CD4 knockout and SCID mutant mice to the disease induced by the murine AIDS defective virus. J. Virol. 71:1997;3013-3022.
56. Tang Y., Fredrickson T. N., Chattopadhyay S. K., Hartley J. W., Morse H. C. III. Lymphomas in mice with retrovirus-induced immunodeficiency. Curr. Top. Microbiol. Immunol. 182:1992;395-398.
57. Tang Y., Chattopadhyay S. K., Hartley J. W., Fredrickson T. N., Morse H. C. 3rd. Clonal outgrowths of T and B cells in SCID mice reconstituted with cells from mice with MAIDS. In Vivo. 8:1994;953-959.
58. Tang Y., Kim W. K., Holmes K. L., Hugin A. W., Kenny J. J., Chattopadhyay S. K., Hartley J. W., Morse H. C. 3rd. Contribution of b cell subsets to delayed development of maids in xid mice. Cell. Immunol. 165:1995;1-6.
59. Veronesi A., Coppola V., Veronese M. L., Menin C., Bruni L., D'Andrea E., Mion M., Amadori A., Chieco-Bianchi L. Lymphoproliferative disease in human peripheral-blood-mononuclear-cell-injected scid mice. II. Role of host and donor factors in tumor generation. Int. J. Cancer. 59:1994;676-683.
60. Ward S. G. CD28: A signalling perspective. Biochem. J. 318:1996;361-377.
61. Whiteside T. L., Herberman R. B. The role of natural killer cells in immune surveillance of cancer. Curr. Opin. Immunol. 7:1995;704-710.
62. Yetter R. A., Buller R. M. L., Lee J. S., Elkins K. L., Mosier D. E., Fredrickson T. N., Morse H. C. III. CD4+ T cells are required for development of a murine retrovirus-induced immunodeficiency syndrome (MAIDS). J. Exp. Med. 168:1988;623-635.